Form 4 for QUCY Quantum Cyber N.V.
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-13 · accession 0001213900-26-018497 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | 2026-02-13 | QUCY | BAECHLER GUIDO | CEO, Dir | A - Grant | $0.00 | +440.0K | 605.1K | +267% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-13 | A | A | 440,000 | $0.00 | 605,058 | D | — | — | (F1) Grant of restricted shares under Mainz Biomed N.V. 2025 Omnibus Incentive Plan; no cash consideration paid. (F2) 6,362 ordinary shares held, and 158,696 employee stock options were granted and previously reported on a Form 3 filed January 26, 2026. |